对脂质转移蛋白过敏或对非类固醇抗炎药物过敏?
Magdalena Rydzyńska1, Kinga Lis2, Zbigniew Bartuzi2
1Clinic of Allergology, Clinical Immunology and Internal Diseases, Jan Biziel University Hospital No. 2 in Bydgoszcz, Ujejskiego 75, 85-168 Bydgoszcz, Poland.
International journal of molecular sciences
|July 12, 2025
概括
一名妇女在吃了葡萄并服用非类固醇抗炎药物 (NSAID) ketoprofen 后出现过敏反应. 这突显了脂质转移蛋白 (LTP) 和NSAIDs作为严重过敏反应的辅助因子的作用.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 临床医学 临床医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 众所周知,非类固醇抗炎药物 (NSAID) 会引起过敏反应,并且可以作为过敏反应的辅助因子.
- 脂质转移蛋白 (LTP) 是植物衍生的过敏原,其中辅因子显著影响过敏反应.
研究的目的:
- 在怀疑LTP过敏的患者中报告过敏症的病例.
- 调查烯在观察到的过敏反应中作为辅助因子的作用.
主要方法:
- 一个26岁的女性在摄入葡萄和使用洛芬后出现过敏反应的病例报告.
- 诊断工作包括皮肤刺伤测试,ALEX多参数测定LTP抗体,以及药物诱导测试 (二,乙酸,布洛芬).
主要成果:
- 患者出现过敏反应症状,包括唇/舌头/喉胀,呼吸不全,头和失去意识.
- 对花生和子的皮肤刺伤测试呈阳性,ALEX测试检测了多个LTP抗体.
- 皮内托芬测试呈阳性;乙酸盐和布洛芬被耐受.
- 确立了LTP过敏和选择性氨过敏的诊断.
结论:
- 脂质转移蛋白 (LTP) 过敏可能与严重反应相关,可能会被NSAIDs加剧.
- 在这个病人身上发现了对非类固醇抗炎药物 (NSAID) 托芬的选择性过敏.
- 管理包括严格避免食用含有烯和LTP的食物.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
878
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
878
Hypersensitivities
1.1K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
1.1K
Allergic Drug Reactions
981
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
981
Antiasthma Drugs: Leukotriene Modifiers
486
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
486
Nephrotic Syndrome I : Introduction
31
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
31
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
237
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
237


